ARCT
Closed
Arcturus Therapeutics Holdings Inc
12.99
-0.02 (-0.15%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 13.01
Day's Range: 12.65 - 13.74
Send
sign up or login to leave a comment!
When Written:
23.97
Arcturus Therapeutics Holdings Inc is a biopharmaceutical company focused on developing RNA medicines to treat rare diseases. The company's proprietary RNA technologies allow for the efficient delivery of RNA therapeutics to target cells and tissues, enabling the development of treatments for diseases that were previously considered untreatable. Arcturus has a pipeline of RNA medicines in various stages of development, including treatments for cystic fibrosis, ornithine transcarbamylase deficiency, and COVID-19. The company is headquartered in San Diego, California and was founded in 2013. It is publicly traded on the Nasdaq stock exchange under the ticker symbol ARCT.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








